Committee chair
Abstract
The IBFM ALL Committee is a network that shares published and unpublished basic science and clinical trials data from AIEOP/BFM, ALLTogether, ALL-IC, Australian, and Japanese collaborators to promote the development of more effective and less toxic treatment strategies for childhood acute lymphoblastic leukemia (ALL). The committee and its members collaborate closely with US groups (The Children’s Oncology Group, St Jude Children’s Research Hospital, and the Dana Farber Consortium), including within the so-called Ponte di Legno consortium (PdL)) that share data on rare ALL subsets for the development of future clinical trials.
Committee members participate in organizing interim ALL meetings in Milan (January, annually), SIOPE meetings (annually), PdL meetings (at 1-2 years intervals), and in-between online meetings.
The committee chair is member of the IBFM Board, and the committee works closely with the other IBFM committees to promote research, meetings, and educational activities.
Scientific aim
- To promote the development of more effective and less toxic treatment strategies for ALL
Open clinical trials
-
AIEOP-BFM ALL 2017 (2017 – )
Randomized clinical trial for ALL (age 1-18y)
-
ALL-IC 2022 (3/2023 – )
Randomized clinical trial for ALL in countries with limited resources
-
ALLTogether-1 (2021 – )
Randomized clinical trial for ALL (age up to 45 years)
-
EsPhALL2017-COGAALL1631
Randomized trial for patients with Ph+ ALLAIEOP-BFM ALL 2017 (2017-2023): Randomized clinical trial (age 1.0-21.9y)
-
Interfant-21 (2/2023 – )
Non-randomized clinical trial for all pts under 1y of age with KMT2A rear. ALL
Completed clinical trials
-
AIEOP-BFM ALL 2000 (2000-2006)
Randomized clinical trial for ALL (age 1-18y)
-
AIEOP-BFM ALL 2009
Randomized clinical trial for ALL (age 1-18y)
-
ALL IC-BFM 2009 (2010-2018)
Randomized clinical trial for ALL in countries with limited resources
-
ALL-SCT BFM 2003
HSCT in VHR ALL
-
ALLIC-BFM 2002 (2002-2009)
Randomized clinical protocol for ALL in countries with limited resources
-
EsPhALL (2004-2009)
ALL positive for the t(9;22)[BCR/ABL] translocation
-
IDH (1991-1995)
SR ALL
-
INTERFANT-06
Randomized clinical trial for ALL under 1y
-
Interfant-99 (1999-2006)
ALL below the age of one year (ALL<1y)
-
VCR/Steroid Pulses (1995-2000)
MR ALL
-
hSCT in VHR ALL (1995-2000)
Selected publications
Committee members
- Andishe Attarbaschi
- Andre Baruchel
- Andrea Biondi
- Arndt Borkhardt
- Myriam Campbell
- Gunnar Cario
- Luis Castillo
- Valentino Conter
- Ximo Duarte
- Sarah Elitzur
- Gaby Escherich
- Marisa Felice
- Chris Halsey
- Mats Heyman
- Shai Izraeli
- Csongor Kiss
- Alexandra Kolenova
- Gabor Kovacs
- Franco Locatelli
- Olli Lohi
- Atsushi Manabe
- Veerle Mondelaers
- Anthony Moorman
- J John Moppett
- Anja Möricke
- Rob Pieters
- Susana Rives
- Carmelo Rizzari
- Sujith Samarasinghe
- Kjeld Schmiegelow
- Martin Schrappe
- Owen Smith
- Marin Stanulla
- Jan Stary
- Marion Strullu
- Tomasz Szczepanski
- Toby Trahair
- Anne Uyttebroeck
- Maria Grazia Valsecchi
- Inge van der Sluis
- Luciana Vinti
- Ajay Vora
- Martin Zimmermann